GO:0004771 sterol ester esterase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004771 (sterol ester esterase activity) catalyzes the hydrolysis of a sterol ester into a free fatty acid and a sterol, releasing a proton.
• The reaction is central to cholesterol and sterol homeostasis, mobilizing stored sterol esters from lipid droplets and lipoprotein particles.
• Key enzymes include hormone-sensitive lipase (LIPE), neutral cholesterol ester hydrolase (NCEH1), and lipid droplet-associated hydrolase (LDAH).
• Loss of neutral cholesterol ester hydrolytic activity causes adrenal enlargement and impaired steroidogenesis in mouse models.
• Sterol ester hydrolysis influences atherosclerosis, foam cell formation, and adrenal steroid hormone production.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable precise interrogation of sterol ester esterase genes in metabolic and cardiovascular research.
Description
Sterol ester esterase activity (GO:0004771) is a molecular function that catalyzes the hydrolysis of a sterol ester into a free fatty acid and a sterol, releasing a proton. This activity is essential for mobilizing stored sterol esters, which are abundant in lipid droplets and lipoprotein particles, and for generating free sterols that serve as substrates for steroid hormone synthesis, membrane biogenesis, and signaling. In mammals, the reaction is carried out by several enzymes, including hormone-sensitive lipase (LIPE), neutral cholesterol ester hydrolase (NCEH1), and lipid droplet-associated hydrolase (LDAH), each with distinct tissue distributions and regulatory properties. Researchers study GO:0004771 because its dysregulation is linked to atherosclerosis, adrenal dysfunction, and metabolic disorders. Understanding the enzymes, substrates, and regulatory mechanisms of sterol ester hydrolysis provides a foundation for developing targeted therapies and for designing CRISPR-based models to dissect gene function.
sterol ester esterase activity At A Glance
| GO ID | GO:0004771 |
|---|---|
| GO term | sterol ester esterase activity |
| Ontology | molecular_function |
| Synonym | cholesterol esterase activity; cholesteryl ester hydrolase activity; sterol ester hydrolase activity; acylcholesterol lipase activity; triterpenol esterase activity |
| Major function | Hydrolysis of sterol esters to free fatty acids and sterols |
| Reaction | a sterol ester + H2O = a fatty acid + a sterol + H+ |
| Substrates | Sterol esters (e.g., cholesteryl esters, plant sterol esters) |
| Products | Free fatty acids and free sterols (e.g., cholesterol) |
| Cellular context | Lipid droplets, endoplasmic reticulum, plasma membrane, lipoprotein particles |
What Is GO:0004771?
GO:0004771 (sterol ester esterase activity) is defined as the catalysis of the reaction: a sterol ester + H2O = a fatty acid + a sterol + H+. In other words, it is the enzymatic removal of a fatty acid from a sterol ester, yielding a free sterol and a free fatty acid. This activity is also known by synonyms such as cholesterol esterase activity, cholesteryl ester hydrolase activity, and sterol ester hydrolase activity.
Why Is sterol ester esterase activity Important in Cell Biology?
Sterol ester esterase activity is critical for maintaining sterol homeostasis and for providing free cholesterol for steroidogenesis, membrane synthesis, and signaling. Dysregulation of this activity contributes to atherosclerosis, adrenal disorders, and metabolic diseases, making it a key target for research and therapeutic intervention.
• Mobilizes stored sterol esters from lipid droplets for energy and membrane synthesis.
• Provides free cholesterol for steroid hormone production in adrenal and gonadal tissues.
• Prevents excessive cholesteryl ester accumulation in macrophages, reducing foam cell formation.
• Loss of neutral cholesterol ester hydrolytic activity leads to adrenal enlargement and impaired stress response.
• Modulates liver X receptor (LXR) signaling by generating sterol ligands.
• Influences atherosclerosis development and plaque stability.
• Plays a role in plant sterol ester metabolism and non-alcoholic fatty liver disease.
• Bacterial and fungal sterol esterases have biotechnological applications.
• Serves as a target for drug discovery in dyslipidemia and cardiovascular disease.
• Enables precise gene function studies through CRISPR knockout and knock-in models.
Molecular Mechanism of sterol ester esterase activity
Substrate recognition and binding
In simple terms: The enzyme grabs a sterol ester molecule and positions it for cleavage.
Sterol ester esterases recognize sterol esters, such as cholesteryl esters, through hydrophobic binding pockets that accommodate the sterol ring and the fatty acyl chain. The enzyme-substrate complex forms at the lipid-water interface of lipid droplets or lipoprotein particles, where the ester bond is exposed to the catalytic site.
Catalytic hydrolysis
In simple terms: Water breaks the ester bond, releasing a fatty acid and a sterol.
The catalytic mechanism involves a serine hydrolase triad (serine, histidine, aspartate) that activates a water molecule for nucleophilic attack on the ester carbonyl, resulting in the release of a free fatty acid and a free sterol. This reaction is conserved across hormone-sensitive lipase (LIPE), neutral cholesterol ester hydrolase (NCEH1), and lipid droplet-associated hydrolase (LDAH).
Product release and cellular fate
In simple terms: The freed sterol and fatty acid are used by the cell or exported.
Free sterols can be re-esterified, used for membrane synthesis, or serve as ligands for nuclear receptors such as LXR. Free fatty acids can be oxidized for energy or re-esterified into triglycerides. In adrenal cells, free cholesterol is rapidly converted to steroid hormones.
Regulation by hormones and nutrients
In simple terms: Hormones and nutrients tell the enzyme when to be active.
Hormone-sensitive lipase (LIPE) is activated by catecholamines and inhibited by insulin, linking sterol ester hydrolysis to energy status. Nutrient availability and cellular cholesterol levels also regulate the expression and activity of NCEH1 and LDAH.
Tissue-specific isoenzymes and localization
In simple terms: Different enzymes do the same job in different tissues.
LIPE is highly expressed in adipose tissue and adrenal glands, NCEH1 is abundant in macrophages and liver, and LDAH is associated with lipid droplets in various tissues. This tissue-specific distribution allows fine-tuned regulation of sterol ester hydrolysis according to physiological demands.
Key Genes Involved in GO:0004771 sterol ester esterase activity
The following genes encode enzymes with sterol ester esterase activity or are directly involved in sterol ester hydrolysis and related metabolic pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LIPE | Hormone-sensitive lipase; hydrolyzes cholesteryl esters and triglycerides | Key regulator of lipolysis and steroidogenesis; target for metabolic disease |
| NCEH1 | Neutral cholesterol ester hydrolase; hydrolyzes cholesteryl esters in macrophages | Protects against foam cell formation and atherosclerosis |
| LDAH | Lipid droplet-associated hydrolase; mobilizes LXR sterol ligands | Links lipid droplet hydrolysis to LXR signaling and atherosclerosis |
| LPL | Lipoprotein lipase; has sterol ester hydrolytic activity | Role in lipoprotein metabolism and bacterial sterol ester hydrolysis |
| CEL | Carboxyl ester lipase; bile salt-stimulated cholesterol esterase | Cholesterol absorption and reverse cholesterol transport |
| PLA2G15 | Lysosomal phospholipase A2; may hydrolyze sterol esters | Lysosomal lipid metabolism and macrophage function |
| ABHD5 | Activator of ATGL; indirectly affects sterol ester hydrolysis | Lipid droplet lipolysis regulation |
| PNPLA2 | Adipose triglyceride lipase; acts on triglycerides and possibly sterol esters | Energy homeostasis and lipid storage |
| SOAT1 | Sterol O-acyltransferase 1; opposite reaction (esterification) | Balance of esterification/hydrolysis in cells |
| SOAT2 | Sterol O-acyltransferase 2; esterifies cholesterol | Intestinal cholesterol absorption |
| NR1H3 | Liver X receptor alpha; activated by sterol ligands | Transcriptional regulation of cholesterol metabolism |
| NR1H2 | Liver X receptor beta; activated by sterol ligands | Cholesterol efflux and inflammation |
| SCARB1 | Scavenger receptor class B member 1; HDL receptor | Selective cholesterol uptake and sterol ester hydrolysis |
| APOA1 | Apolipoprotein A-I; major HDL protein | Reverse cholesterol transport and sterol ester metabolism |
| APOB | Apolipoprotein B; LDL and VLDL component | Lipoprotein assembly and cholesterol delivery |
| CYP11A1 | Cholesterol side-chain cleavage enzyme | First step in steroidogenesis using free cholesterol |
| STAR | Steroidogenic acute regulatory protein | Cholesterol transport into mitochondria for steroidogenesis |
How Is sterol ester esterase activity Regulated?
Sterol ester esterase activity is regulated at multiple levels. Hormone-sensitive lipase (LIPE) is activated by protein kinase A-mediated phosphorylation in response to catecholamines and inhibited by insulin, linking sterol ester hydrolysis to energy demand. Neutral cholesterol ester hydrolase (NCEH1) and lipid droplet-associated hydrolase (LDAH) are regulated by cellular cholesterol levels and inflammatory signals, with LDAH specifically mobilizing LXR ligands to modulate gene expression. Additionally, the balance between esterification by SOAT1/SOAT2 and hydrolysis by esterases determines the size and composition of cellular sterol ester pools.
sterol ester esterase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LDAH | Atherosclerosis, LXR signaling | Ldah knockout mouse; macrophage-specific KO |
| NCEH1 | Adrenal enlargement, atherosclerosis | Nceh1 knockout mouse; adrenal cell line KO |
| LIPE | Dyslipidemia, obesity, diabetes | Lipe knockout mouse; adipocyte-specific KO |
| CEL | Cholesterol absorption disorders | Cel knockout mouse; intestinal cell line |
| SOAT1 | Atherosclerosis, cholesterol esterification | Soat1 knockout mouse; macrophage KO |
Atherosclerosis and foam cell formation
Impaired sterol ester hydrolysis leads to cholesteryl ester accumulation in macrophages, promoting foam cell formation and atherosclerosis. LDAH deficiency increases lipid droplet cholesteryl esters and accelerates atherosclerosis in mice, while NCEH1 ablation exacerbates plaque development.
Adrenal dysfunction and steroidogenesis
Loss of neutral cholesterol ester hydrolytic activity causes adrenal enlargement and impaired corticosteroid production, as free cholesterol is required for steroid hormone synthesis. This highlights the essential role of sterol ester esterases in adrenal physiology.
Non-alcoholic fatty liver disease (NAFLD)
Plant sterol esters of α-linolenic acid improve NAFLD by attenuating endoplasmic reticulum stress and apoptosis via AMPK activation, suggesting that sterol ester metabolism influences hepatic lipid homeostasis.
Metabolic syndrome and dyslipidemia
Altered sterol ester esterase activity affects circulating lipoprotein levels and energy storage, contributing to dyslipidemia and insulin resistance. Hormone-sensitive lipase is a key regulator of lipolysis and its dysfunction is linked to obesity and diabetes.
From sterol ester esterase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of LDAH increase atherosclerosis? | Ldah knockout mouse (constitutive or macrophage-specific) |
| Does NCEH1 deficiency cause adrenal enlargement? | Nceh1 knockout mouse; adrenal cell line KO |
| How does LIPE phosphorylation regulate sterol ester hydrolysis? | Point mutation of PKA sites in Lipe (knock-in mouse) |
| Can overexpression of NCEH1 reduce foam cell formation? | Macrophage-specific Nceh1 overexpression (transgenic or lentiviral) |
| What is the role of LDAH in LXR ligand production? | Ldah knockout hepatocytes; tagged knock-in for localization |
| Does plant sterol ester hydrolysis affect NAFLD? | Mouse model of NAFLD treated with plant sterol esters |
How to Study the sterol ester esterase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorogenic esterase assay | Hydrolytic activity on sterol ester analogs | High-throughput screening of enzyme inhibitors |
| Radioactive substrate assay | Release of free fatty acids from labeled cholesteryl esters | Quantification of enzyme kinetics in cell lysates |
| Lipidomics (LC-MS) | Sterol ester and free sterol species | Profiling lipid changes in knockout cells |
| CRISPR knockout screen | Genes affecting sterol ester levels | Discovery of novel regulators |
| Western blot | Protein expression of LIPE, NCEH1, LDAH | Validation of knockout or overexpression |
| Immunofluorescence | Subcellular localization of enzymes | Co-localization with lipid droplets |
| qRT-PCR | mRNA levels of sterol ester esterases | Gene expression analysis after treatment |
| Steroid hormone measurement | Corticosterone or cortisol production | Adrenal function in knockout models |
Enzymatic activity assays
Sterol ester esterase activity can be measured using fluorogenic or radioactive substrates, such as cholesteryl [14C]oleate, in cell lysates or purified enzyme preparations. These assays quantify the release of free fatty acids or sterols and are used to validate enzyme function after CRISPR editing.
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics enables comprehensive profiling of sterol esters and free sterols in cells and tissues, revealing changes in lipid droplet composition upon genetic manipulation. This method is essential for linking enzyme activity to cellular lipid homeostasis.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout screens can identify genes that regulate sterol ester hydrolysis and cholesterol metabolism. Such screens are powerful for discovering novel regulators and for validating candidate genes in metabolic pathways.
Imaging and subcellular localization
Fluorescence microscopy with tagged proteins (e.g., GFP-LDAH) and lipid droplet dyes (e.g., BODIPY) allows visualization of enzyme localization and lipid droplet dynamics in live cells. This approach provides spatial context for sterol ester hydrolysis.
How CRISPR Can Be Used to Study GO:0004771 sterol ester esterase activity
Knockout
CRISPR knockout of genes encoding sterol ester esterases (e.g., LDAH, NCEH1, LIPE) enables loss-of-function studies to determine their contribution to lipid metabolism, atherosclerosis, and steroidogenesis. Knockout cell lines and mice are used to measure changes in sterol ester hydrolysis, lipid droplet accumulation, and disease phenotypes.
Point Mutation
Point mutations can be introduced into catalytic residues (e.g., serine in the hydrolase triad) or regulatory phosphorylation sites to dissect enzyme mechanism and regulation. Such models help distinguish catalytic activity from protein-protein interactions.
Knock-in
Knock-in of tagged versions (e.g., GFP or FLAG) of sterol ester esterases allows real-time tracking of localization and interaction partners. Knock-in of disease-associated variants can model human mutations in sterol ester metabolism.
Overexpression
Overexpression of sterol ester esterases (e.g., NCEH1, LDAH) in cell lines or transgenic mice can test whether increased hydrolysis protects against foam cell formation or enhances steroidogenesis. Overexpression models are valuable for gain-of-function studies and drug target validation.
How EDITGENE Supports sterol ester esterase activity Research
Researchers studying sterol ester esterase activity-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, atherosclerosis, or adrenal function. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell and animal models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for sterol ester esterase activity research.
Frequently Asked Questions About sterol ester esterase activity
What is sterol ester esterase activity?
Sterol ester esterase activity (GO:0004771) is the enzymatic hydrolysis of a sterol ester into a free fatty acid and a sterol, releasing a proton.
What genes are involved in sterol ester esterase activity?
Key genes include LIPE, NCEH1, LDAH, CEL, and LPL, which encode enzymes that hydrolyze sterol esters.
What is the reaction catalyzed by sterol ester esterase?
The reaction is: a sterol ester + H2O = a fatty acid + a sterol + H+.
How is sterol ester esterase activity regulated?
It is regulated by hormones (e.g., catecholamines, insulin), nutrients, and cellular cholesterol levels, often through phosphorylation of enzymes like LIPE.
What diseases are associated with impaired sterol ester hydrolysis?
Atherosclerosis, adrenal dysfunction, non-alcoholic fatty liver disease, and dyslipidemia are linked to altered sterol ester esterase activity.
What are the synonyms for sterol ester esterase activity?
Synonyms include cholesterol esterase activity, cholesteryl ester hydrolase activity, sterol ester hydrolase activity, and acylcholesterol lipase activity.
How can I study sterol ester esterase activity in the lab?
Common methods include fluorogenic or radioactive substrate assays, lipidomics, Western blot, and CRISPR knockout models.
What is the role of LDAH in sterol ester metabolism?
LDAH is a lipid droplet-associated hydrolase that mobilizes LXR sterol ligands and protects against atherosclerosis.
Does NCEH1 deficiency affect adrenal function?
Yes, loss of neutral cholesterol ester hydrolytic activity causes adrenal enlargement and impaired steroidogenesis.
Can CRISPR be used to model sterol ester esterase-related diseases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to study these genes in metabolic and cardiovascular research.
Conclusion
Sterol ester esterase activity (GO:0004771) is a fundamental molecular function that governs the hydrolysis of sterol esters, impacting cholesterol homeostasis, steroidogenesis, and atherosclerosis. Understanding its mechanisms and regulation provides insights into metabolic diseases and offers targets for therapeutic intervention. CRISPR-based models are indispensable for dissecting the roles of specific genes and for translating findings into clinical applications.
References
- 1. Goo YH et al.. 2024. Lipid droplet-associated hydrolase mobilizes stores of liver X receptor sterol ligands and protects against atherosclerosis.. Nat Commun 15(1):6540 PMID: 39095402
- 2. Kraemer FB. 2007. Adrenal cholesterol utilization.. Mol Cell Endocrinol 265-266:42-5 PMID: 17208360
- 3. Yu XH et al.. 2013. Foam cells in atherosclerosis.. Clin Chim Acta 424:245-52 PMID: 23782937
- 4. Ohta K et al.. 2011. Abrogation of neutral cholesterol ester hydrolytic activity causes adrenal enlargement.. Biochem Biophys Res Commun 404(1):254-60 PMID: 21111707
- 5. Han H et al.. 2022. Plant sterol ester of α-linolenic acid improved non-alcoholic fatty liver disease by attenuating endoplasmic reticulum stress-triggered apoptosis via activation of the AMPK.. J Nutr Biochem 107:109072 PMID: 35660097
- 6. Haemmerle G et al.. 2003. Letting lipids go: hormone-sensitive lipase.. Curr Opin Lipidol 14(3):289-97 PMID: 12840660
- 7. Kim YA et al.. 2025. Antibacterial Activity of a Linolenic Acid Stigmasterol Ester Produced by Lipase-Mediated Transesterification.. J Microbiol Biotechnol 35:e2410055 PMID: 39947702
- 8. Sugiura M et al.. 1976. Sterol ester hydrolytic activity of lipoprotein lipase from Pseudomonas fluorescence.. Chem Pharm Bull (Tokyo) 24(6):1202-8 PMID: 828527
